Monte Rosa Therapeutics, Inc. - GLUE

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$1.486B

QoQ value delta ($000)

+$466.8M (+45.8%)

Implied price effect (QoQ)

+4.73%

Total shares

90,501,248

QoQ shares delta

+25,492,994 (+39.22%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 190 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
NEA Management Company, LLC	126,538	7,692,298	7.19%
PRICE T ROWE ASSOCIATES INC /MD/	110,549	6,720,188	0.01%
BlackRock, Inc.	92,739	5,637,684	0.0%
TCG Crossover Management, LLC	76,034	4,622,151	2.18%
BVF INC/IL	73,381	4,460,886	2.34%
BAKER BROS. ADVISORS LP	71,487	4,345,736	0.41%
SUVRETTA CAPITAL MANAGEMENT, LLC	69,531	4,226,809	1.78%
Vestal Point Capital, LP	59,276	3,603,465	1.66%
STATE STREET CORP	55,172	3,353,980	0.0%
BRAIDWELL LP	52,748	3,206,574	1.76%
Versant Venture Management, LLC	52,323	3,180,780	37.0%
VANGUARD CAPITAL MANAGEMENT LLC	50,999	3,100,245	0.0%
VANGUARD GROUP INC	50,905	3,246,500	0.0%
AMERICAN CENTURY COMPANIES INC	46,218	2,809,647	0.02%
SILVERARC CAPITAL MANAGEMENT, LLC	32,933	2,002,040	3.36%
Aisling Capital Management LP	25,590	1,555,664	5.37%
GEODE CAPITAL MANAGEMENT, LLC	25,352	1,540,812	0.0%
MARSHALL WACE, LLP	23,575	1,433,152	0.02%
Bellevue Group AG	20,562	1,250,000	0.49%
MPM BioImpact LLC	19,360	1,176,928	1.5%
DIMENSIONAL FUND ADVISORS LP	17,124	1,041,372	0.0%
FMR LLC	16,849	1,024,304	0.0%
GOLDMAN SACHS GROUP INC	16,475	1,001,527	0.0%
Frazier Life Sciences Management, L.P.	16,450	1,000,000	0.42%
NORTHERN TRUST CORP	13,597	826,624	0.0%